{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:05:22Z","timestamp":1773716722683,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug use during pregnancy should be evidence-based and favor the safest and most appropriate prescription. The Italian Medicines Agency (AIFA) coordinates a network focusing on monitoring medication use in pregnancy. Hypertensive disorders are common medical complication of pregnancy and antihypertensive therapy is prescribed to reduce the risk of adverse feto-maternal complications. The objective of this study is to highlight the prescription pattern of antihypertensive drugs before pregnancy, during pregnancy and in the postpartum period in Italy and to evaluate their use with a specific attention to the prescription pattern of drugs considered safe during pregnancy. A multi-database cross-sectional population study using a Common Data Model (CDM) was performed. We selected all women aged 15\u201349\u00a0years living in eight Italian regions who gave birth in hospital between 1 April 2016 and 31 March 2018. In a cohort of 449.012 women, corresponding to 59% of Italian deliveries occurred in the study period, the prevalence of prescription of antihypertensive drugs in the pre-conceptional period was 1.2%, in pregnancy 2.0% and in the postpartum period 2.9%. Beta-blockers were the most prescribed drugs before pregnancy (0.28%\u20130.30%). Calcium channel blockers were the most prescribed drugs during pregnancy, with a prevalence of 0.23%, 0.33%, 0.75% in each trimester. Alfa-2-adrenergic receptor agonists were the second most prescribed during pregnancy with a prevalence of 0.16%, 0.26% and 0.55% in each trimester. The prescription of drugs contraindicated during pregnancy was below 0.5%. Only a small percentage of women switched from a contraindicated drug to a drug compatible with pregnancy. The analysis showed little variability between the different Italian regions. In general, the prescription of antihypertensive drugs in the Italian Mom-Network is coherent with the drugs compatible with pregnancy.<\/jats:p>","DOI":"10.3389\/fphar.2024.1370797","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T11:08:46Z","timestamp":1725016126000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Antihypertensive therapy during pregnancy: the prescription pattern in Italy"],"prefix":"10.3389","volume":"15","author":[{"given":"Anna","family":"Locatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00f2","family":"Bellante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Donatiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Fortinguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Belleudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca R.","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002252.pub4","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2018","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B2","volume-title":"I disordini ipertensivi in gravidanza: classificazione, diagnosi e terapia","year":"2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s13063-023-07582-9","article-title":"A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA)","volume":"24","author":"Ashworth","year":"2023","journal-title":"Trials"},{"key":"B4","doi-asserted-by":"publisher","first-page":"699062","DOI":"10.3389\/fphar.2021.699062","article-title":"The Italian network for monitoring medication use during pregnancy (MoM-Net): experience and perspectives","volume":"12","author":"Belleudi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40292-013-0019-y","article-title":"Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). [corrected]","volume":"20","author":"Borghi","year":"2013","journal-title":"High Blood Press. and Cardiovasc. Prev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11906-018-0865-z","article-title":"Resistant hypertension in pregnancy: how to manage?","volume":"20","author":"Bortolotto","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1471-0528.2000.tb13342.x","article-title":"Nifedipine administered in pregnancy: effect on the development of children at 18 months","volume":"107","author":"Bortolus","year":"2000","journal-title":"BJOG"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101368","DOI":"10.1016\/j.ajogmf.2024.101368","article-title":"The \u201cPreeclampsia and Hypertension Target Treatment\u201d study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings","volume":"6","author":"di Pasquo","year":"2024","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"B9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1600-0412.2012.01352.x","article-title":"Obstetric near\u2010miss cases among women admitted to intensive care units in Italy","volume":"91","author":"Donati","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.preghy.2011.01.001","article-title":"Antihypertensive drug prescription pattern before and during pregnancy in France","volume":"1","author":"Duhalde","year":"2011","journal-title":"Pregnancy Hypertens. Int. J. Women\u2019s Cardiovasc. Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD001449","DOI":"10.1002\/14651858.CD001449.pub2","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J. Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e3453","DOI":"10.1002\/dmrr.3453","article-title":"Increased risk of major congenital malformations in early pregnancy use of angiotensin\u2010converting\u2010enzyme inhibitors and angiotensin\u2010receptor\u2010blockers: a meta\u2010analysis","volume":"37","author":"Fu","year":"2021","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstetrics Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cpt.1833","article-title":"Different strategies to execute multi\u2010database studies for Medicines surveillance in real\u2010world setting: a reflection on the European Model","volume":"108","author":"Gini","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1471-0528.1998.tb10201.x","article-title":"Nifedipine versus expectant management in mild to moderate hypertension in pregnancy","volume":"105","year":"1998","journal-title":"BJOG"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2018.07.002","article-title":"Contribution of hypertension to severe maternal morbidity","volume":"219","author":"Hitti","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0186287","DOI":"10.1371\/journal.pone.0186287","article-title":"Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"12","author":"Lean","year":"2017","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40292-018-0257-0","article-title":"Hypertension and pharmacological therapy in women","volume":"25","author":"Lodi","year":"2018","journal-title":"High Blood Press. and Cardiovasc. Prev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.111.187039","article-title":"Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies","volume":"59","author":"Macdonald-Wallis","year":"2012","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/HYPERTENSIONAHA.113.02766","article-title":"Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort","volume":"64","author":"Macdonald-Wallis","year":"2014","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"CD004351","DOI":"10.1002\/14651858.CD004351.pub3","article-title":"Prevention and treatment of postpartum hypertension","author":"Magee","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (control of hypertension in pregnancy study)","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"B27","volume-title":"Hypertension in pregnancy: diagnosis and management","year":"2019"},{"key":"B28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.preghy.2017.10.011","article-title":"Pregnancy outcomes in women with previous gestational hypertension: a cohort study to guide counselling and management","volume":"12","author":"Nzelu","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/cpt.1577","article-title":"Choosing among common data models for real\u2010world data analyses fit for making decisions about the effectiveness of medical products","volume":"107","author":"Schneeweiss","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S1222","DOI":"10.1016\/j.ajog.2020.08.018","article-title":"Guidelines\u2014similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension","volume":"226","author":"Scott","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.003904","article-title":"Chronic hypertension in pregnancy","volume":"129","author":"Seely","year":"2014","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/OGX.0000000000000942","article-title":"Gestational hypertension and preeclampsia: an overview of national and international guidelines","volume":"76","author":"Tsakiridis","year":"2021","journal-title":"Obstet. Gynecol. Surv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.preghy.2017.11.006","article-title":"Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: a systematic review","volume":"11","author":"Ukah","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"B37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12889-018-5545-z","article-title":"Drug prescribing during pregnancy in a central region of Italy, 2008-2012","volume":"18","author":"Ventura","year":"2018","journal-title":"BMC Public Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e005526","DOI":"10.1161\/JAHA.117.005526","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta\u2010analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J. Am. Heart Assoc."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1370797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T11:08:51Z","timestamp":1725016131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1370797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":38,"alternative-id":["10.3389\/fphar.2024.1370797"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1370797","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"article-number":"1370797"}}